Here are the 10-K annual reports from Solesence, Inc. (SLSN) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow SLSN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SLSN filings page.
Solésence, Inc. filed Amendment No. 1 to its annual report to add Exhibit 97.1, which was inadvertently omitted from the original filing. The company states that no other items are being revised and the amendment does not reflect events after the original report.
The aggregate market value of voting stock held by non‑affiliates was $27,254,231 as of June 30, 2025, and 70,632,445 common shares were outstanding as of March 30, 2026. The filing also lists numerous previously filed material contracts, loan agreements, employment agreements, and the Solésence 2025 Equity Compensation Plan as exhibits.
Solésence, Inc. reports strong 2025 growth as it advances its rebranding from Nanophase Technologies into a skin-health focused consumer products company. Total revenue rose to $62,064, driven mainly by prestige beauty consumer products built on its Active Stress Defense™ technology and mineral-based UV protection APIs.
The company increasingly prioritizes finished “white label” and custom skin-care products over legacy advanced materials, operates two FDA-registered, ISO-certified facilities near Chicago, and invests heavily in R&D and capacity to meet what management describes as unprecedented demand from brand partners.